Science News
from research organizations
Inadequately managed allergies cause significant economic burden in Europe
- Date:
- August 4, 2014
- Source:
- Wiley
- Summary:
- New research in Europe indicates that avoidable indirect costs per patient insufficiently treated for allergy equal 2,405.00 Euros per year due to absence from work and reduced working capacity. On the other hand, appropriate therapy is available at an average cost of 125 Euros per patient annually, which represents only 5 percent of the cost of untreated disease.
- Share:
FULL STORY
New research indicates that avoidable indirect costs per patient insufficiently treated for allergy equal 2,405.00 Euros per year due to absence from work and reduced working capacity.
On the other hand, appropriate therapy is available at an average cost of 125 Euros per patient annually, which represents only 5% of the cost of untreated disease.
"Between 55 and 151 billion Euros EU wide could be saved every year by better management of allergies," said Dr. Torsten Zuberbier, lead author of the Allergy study.
Journal Reference:
- T. Zuberbier, J. Lötvall, S. Simoens, S. V. Subramanian, M. K. Church. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review. Allergy, 2014; DOI: 10.1111/all.12470
Cite This Page:
Wiley. "Inadequately managed allergies cause significant economic burden in Europe." ScienceDaily. ScienceDaily, 4 August 2014. <www.sciencedaily.com
Wiley. (2014, August 4). Inadequately managed allergies cause significant economic burden in Europe. ScienceDaily. Retrieved December 26, 2024 from www.sciencedaily.com
Wiley. "Inadequately managed allergies cause significant economic burden in Europe." ScienceDaily. www.sciencedaily.com
Explore More
from ScienceDaily
RELATED STORIES